Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases

Abstract

Carbohydrates serve as important energy sources and structural substances for human body as well as for gut microbes. As evidenced by the advances in immunometabolism, glucose metabolism and adenosine triphosphate (ATP) generation are deeply involved in immune cell activation, proliferation, and signaling transduction as well as trafficking and effector functions, thus contributing to immune response programming and assisting in host adaption to microenvironment changes. Increased glucose uptake, aberrant expression of glucose transporter 1 (e.g., GLU1), and abnormal glycosylation patterns have been identified in autoimmunity and are suggested as partially responsible for the dysregulated immune response and the modification of gut microbiome composition in the autoimmune pathogenesis. The interaction between gut microbiota and host carbohydrate metabolism is complex and bidirectional. Their impact on host immune homeostasis and the development of autoimmune diseases remains to be elucidated. This review summarized the current knowledge on the crosstalk of glucose metabolism and glycosylation in the host with intestinal microbiota and discussed their possible role in the development and progression of autoimmune diseases. Potential therapeutic strategies targeting glucose metabolism and glycosylation in modulating gut ecosystem and treating autoimmune diseases were discussed as well.

Targeted delivery of TGF-β mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers.

“…5E). This increase was associated with increased cytokine production, likely a direct impact of TGF-β signaling cascades (50,51). For the mito stress test, oxygen consumption rate (OCR) was used to determine oxidative phosphorylation.…”

Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer

“…In summary, we have shown the disease-specific nature of the T-antigen, providing evidence that it could be expressed in both pre-cancerous lesions as well as cancer, being associated with the presence of metastases. The almost exclusive expression of the T-antigen on secretions and very rare detection in epithelial cells suggest possible remodeling of the mucus layer glycocalyx by the microbiome with a potential impact on disease, as suggested by different reports [25,26]. LGD and HGD and cancer (magnification: 400×).…”

Nanozyme as a rising star for metabolic disease management

“…A series of studies have reported that dysregulation of these enzyme activities can lead to imbalances in cellular redox status and impact various metabolic processes, such as glucose and lipid metabolism, as well as carbohydrate metabolism. These disruptions have been implicated in metabolic diseases such as diabetes, obesity, and cardiovascular diseases [ 32 – 34 ]. For example, Otaki et al firstly reported that plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure [ 35 ].…”